大肠炎通过抑制胆酸合成来改善胆固醇性肝病
Wenfang Gui1, Mikal Jacob Hole2, Antonio Molinaro3,4,5
1Department of Medicine III, University Hospital RWTH Aachen, Aachen, 52074, Germany.
Nature communications
|June 6, 2023
概括
由炎症性肠病 (IBD) 引起的炎症意外地通过通过肝细胞NF-κB激活抑制胆酸代谢,防止原发性硬化胆炎 (PSC) 肝损伤和纤维化.
科学领域:
- 肝病学和胃肠病学 肝病学和胃肠学
- 免疫学和炎症 免疫学和炎症
背景情况:
- 原发性硬化性胆管炎 (PSC) 是一种慢性肝病,经常与炎症性肠病 (IBD) 一起发生.
- 在PSC中,将肠道炎症与肝病进展联系在一起的机制尚未完全理解.
- 据假设IBD会恶化PSC的发展和进展.
研究的目的:
- 在小鼠模型中研究大肠炎对胆酸代谢和胆固醇性肝损伤的影响.
- 阐明涉及肠道炎症和肝脏疾病之间的相互作用的分子途径.
主要方法:
- 使用了同时发生IBD和PSC的小鼠模型.
- 分析了胆汁酸代谢和胆固醇性肝损伤标志物.
- 研究了肝细胞NF-κB激活和脂多糖 (LPS) 信号传递的作用.
主要成果:
- 肠道炎症和屏障损害意外改善了急性胆固醇性肝损伤.
- 在慢性结肠炎模型中观察到肝纤维化减少.
- 保护作用独立于微生物胆汁酸的变化.
- 通过LPS激活肝细胞NF-κB抑制了胆酸代谢,无论是体外还是体外.
结论:
- 大肠炎触发的保护电路抑制了PSC中的胆固醇性肝病.
- 肝细胞NF-κB由LPS激活在这种保护机制中起着关键作用.
- 这些发现鼓励PSC的多器官治疗策略.
相关概念视频
Chronic Bowel Disorders: Introduction
492
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
492
Drugs for Treatment of Ulcerative Colitis in IBD
179
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
179
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
204
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
204
Chronic Pancreatitis II: Collaborative Care
116
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
116
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
716
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
716
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
161
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
161


